These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1620298)

  • 21. The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study.
    Muizelaar JP; Zwienenberg M; Rudisill NA; Hecht ST
    J Neurosurg; 1999 Jul; 91(1):51-8. PubMed ID: 10389880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind clinical evaluation of the effect of Nizofenone (Y-9179) on delayed ischemic neurological deficits following aneurysmal rupture.
    Saito I; Asano T; Ochiai C; Takakura K; Tamura A; Sano K
    Neurol Res; 1983; 5(4):29-47. PubMed ID: 6149485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.
    Murayama Y; Malisch T; Guglielmi G; Mawad ME; Viñuela F; Duckwiler GR; Gobin YP; Klucznick RP; Martin NA; Frazee J
    J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage.
    Kawamoto S; Tsutsumi K; Yoshikawa G; Shinozaki MH; Yako K; Nagata K; Ueki K
    J Neurosurg; 2004 Feb; 100(2):236-43. PubMed ID: 15086230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model.
    Nosko M; Weir BK; Lunt A; Grace M; Allen P; Mielke B
    J Neurosurg; 1987 Mar; 66(3):416-22. PubMed ID: 3819837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperacute Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
    Bar B; MacKenzie L; Hurst RW; Grant R; Weigele J; Bhalla PK; Kumar MA; Stiefel MF; Levine JM
    Neurocrit Care; 2016 Apr; 24(2):180-8. PubMed ID: 26198438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans.
    Thomas JE; Rosenwasser RH; Armonda RA; Harrop J; Mitchell W; Galaria I
    Stroke; 1999 Jul; 30(7):1409-16. PubMed ID: 10390315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of vasospasm in the treatment of ruptured intracranial aneurysms.
    Saito I; Ueda Y; Sano K
    J Neurosurg; 1977 Sep; 47(3):412-29. PubMed ID: 894345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
    Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
    J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kassell NF; Disney LB; Grace MG
    J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The angiographical study on cerebral vasospasm following the rupture of intracranial aneurysm (1st report).--Time relationship between vasospasm on angiography and the onset of subarachnoid hemorrhage (aurhor's transl)].
    Niizuma H; Kwak R; Ohi T; Katakura R; Mizoi K; Suzuki J
    No Shinkei Geka; 1978 Aug; 6(8):749-55. PubMed ID: 724078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral vasospasm patterns following aneurysmal subarachnoid hemorrhage: an angiographic study comparing coils with clips.
    Jones J; Sayre J; Chang R; Tian J; Szeder V; Gonzalez N; Jahan R; Vinuela F; Duckwiler G; Tateshima S
    J Neurointerv Surg; 2015 Nov; 7(11):803-7. PubMed ID: 25230840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related multifactorial causes of neurological deterioration after early surgery for aneurysmal subarachnoid hemorrhage.
    Yoshimoto Y; Kwak S
    J Neurosurg; 1995 Dec; 83(6):984-8. PubMed ID: 7490642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute angiographic vasospasm and the incidence of delayed cerebral vasospasm: preliminary results.
    Danura H; Schatlo B; Marbacher S; Kerkeni H; Diepers M; Remonda L; Fathi AR; Fandino J
    Acta Neurochir Suppl; 2015; 120():187-90. PubMed ID: 25366622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Gonzalez NR; Boscardin WJ; Glenn T; Vinuela F; Martin NA
    J Neurosurg; 2007 Dec; 107(6):1101-12. PubMed ID: 18077946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of selective inhibitor of thromboxane A2 synthetase on cerebral vasospasm after early surgery.
    Tani E; Maeda Y; Fukumori T; Nakano M; Kochi N; Morimura T; Yokota M; Matsumoto T
    J Neurosurg; 1984 Jul; 61(1):24-9. PubMed ID: 6539367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage.
    Collignon FP; Friedman JA; Piepgras DG; Pichelmann MA; McIver JI; Toussaint LG; McClelland RL
    Neurocrit Care; 2004; 1(4):441-8. PubMed ID: 16174947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study.
    Suzuki S; Sano K; Handa H; Asano T; Tamura A; Yonekawa Y; Ono H; Tachibana N; Hanaoka K
    Neurol Res; 1989 Jun; 11(2):79-88. PubMed ID: 2569686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.